Biologics now command over 70% of the Orphan Drugs Market, driven by gene therapies, enzyme replacements, and monoclonal antibodies. Approved gene therapies for rare diseases grew from 7 in 2020 to 23 by late 2024, with 40+ candidates in pivotal trials. These therapies address previously untreatable conditions like spinal muscular atrophy and sickle cell disease. Parenteral administration...

As the US orphan drugs market continues to evolve, a deeper understanding of market share dynamics reveals significant insights into its future trajectory. By 2024, the market size is projected to be 53.59 USD, with substantial growth expected to reach approximately 139.43 USD by 2035, showcasing a compound annual growth rate of 9.08%. This growth reflects the increasing demand for orphan...

Executive Summary Systemic Light Chain (AL) Amyloidosis Market: Growth Trends and Share Breakdown CAGR Value The global systemic light chain (AL) amyloidosis market size was valued at USD 2.59 billion in 2025 and is expected to reach USD 3.68 billion by 2033, at a CAGR of 4.50% during the forecast period The key highlights of this Systemic Light Chain (AL) Amyloidosis Market report are key...

Global Executive Summary Acromicric Dysplasia Treatment Market: Size, Share, and Forecast CAGR Value The global acromicric dysplasia treatment market size was valued at USD 50.50 million in 2025 and is expected to reach USD 81.71 million by 2033, at a CAGR of 6.20% during the forecast period The global Acromicric Dysplasia Treatment Market analysis report gives a careful overview of the...